Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
Arcutis Biotherapeutics Stock Climbs After Blockbuster Q1 Results - Arcutis Biotherapeutics (NASDAQ:ARQT) benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Industry veteran with over 40 years of experience in finance, investment management, and investment bankingWESTLAKE VILLAGE, Calif., April 10, 2024 Arcutis Biotherapeutics, Inc. , a.
In his role as the new executive director of the Los Angeles chapter of statewide industry resource and advocacy group Biocom California, Dan Gober’s goal is to provide a boost to the region’s bioscience industry and its local microclusters.
Westlake Village-based immuno-dermatology company Arcutis Biotherapeutics Inc. has received approval from the Food and Drug Administration for a topical foam version of its main drug to treat seborrheic dermatitis in individuals aged 9 and older.